NEFL and familial amyloid neuropathy: As ATTRv amyloidosis is a relatively rapidly progressive disease and, without treatment, fatal 7–12 years after the first disease manifestation [59], it can be hypothesized that this rate of progression contributes to higher NfL levels [23] even when the NIS score is lower than in, e.g., Charcot–Marie–Tooth disease.